IDEAS home Printed from https://ideas.repec.org/r/cup/cbooks/9780521472852.html
   My bibliography  Save this item

Evaluating Health Risks

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Bleichrodt, Han & Crainich, David & Eeckhoudt, Louis, 2003. "Comorbidities and the willingness to pay for health improvements," Journal of Public Economics, Elsevier, vol. 87(11), pages 2399-2406, October.
  2. Jonathan Karnon & Aki Tsuchiya & Paul Dolan, 2005. "Developing a relativities approach to valuing the prevention of non‐fatal work‐related accidents and ill health," Health Economics, John Wiley & Sons, Ltd., vol. 14(11), pages 1103-1115, November.
  3. Dean Jamison & Prabhat Jha & David E. Bloom, 2008. "Disease Control," PGDA Working Papers 3508, Program on the Global Demography of Aging.
  4. Thomas Hammerschmidt & Hans‐Peter Zeitler & Reiner Leidl, 2004. "A utility‐theoretic approach to the aggregation of willingness to pay measured in decomposed scenarios: development and empirical test," Health Economics, John Wiley & Sons, Ltd., vol. 13(4), pages 345-361, April.
  5. Richard T. Carson, 2011. "Contingent Valuation," Books, Edward Elgar Publishing, number 2489.
  6. Gerdtham, Ulf-G. & Johannesson, Magnus, 1999. "New estimates of the demand for health: results based on a categorical health measure and Swedish micro data," Social Science & Medicine, Elsevier, vol. 49(10), pages 1325-1332, November.
  7. Olivier Chanel & Pascale Scapecchi & Jean-Christophe Vergnaud, 2006. "How to correctly assess mortality benefits in public policies," Journal of Environmental Planning and Management, Taylor & Francis Journals, vol. 49(5), pages 759-776.
  8. Grégory Ponthière, 2004. "Incorporating changes in life expectancy into economic growth rates: an application to Belgium, 1867-1997," CREPP Working Papers 0403, Centre de Recherche en Economie Publique et de la Population (CREPP) (Research Center on Public and Population Economics) HEC-Management School, University of Liège.
  9. Don Kenkel, 2006. "WTP- and QALY-Based Approaches to Valuing Health for Policy: Common Ground and Disputed Territory," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 34(3), pages 419-437, July.
  10. Birol, Ekin & Roy, Devesh & Torero, Maximo, 2010. "How safe is my food?: Assessing the effect of information and credible certification on consumer demand for food safety in developing countries," IFPRI discussion papers 1029, International Food Policy Research Institute (IFPRI).
  11. Clarke, Philip M., 1998. "Cost-benefit analysis and mammographic screening: a travel cost approach," Journal of Health Economics, Elsevier, vol. 17(6), pages 767-787, December.
  12. Thomas Klose, 2003. "A utility‐theoretic model for QALYs and willingness to pay," Health Economics, John Wiley & Sons, Ltd., vol. 12(1), pages 17-31, January.
  13. Glenn Blomquist & Karen Blumenschein & Magnus Johannesson, 2009. "Eliciting Willingness to Pay without Bias using Follow-up Certainty Statements: Comparisons between Probably/Definitely and a 10-point Certainty Scale," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 43(4), pages 473-502, August.
  14. Sadique, Z. & Edmunds, W. J. & Devlin, N. & Parkin, D., 2005. "Understanding individuals’ decisions about vaccination: a comparison between Expected Utility and Regret Theory models," Working Papers 05/03, Department of Economics, City University London.
  15. O'Conor, Richard M. & Blomquist, Glenn C., 1997. "Measurement of consumer-patient preferences using a hybrid contingent valuation method," Journal of Health Economics, Elsevier, vol. 16(6), pages 667-683, December.
  16. Gerdtham, Ulf-G & Johannesson, Magnus, 2001. "The relationship between happiness, health, and socio-economic factors: results based on Swedish microdata," Journal of Behavioral and Experimental Economics (formerly The Journal of Socio-Economics), Elsevier, vol. 30(6), pages 553-557.
  17. Fredrik Carlsson & Peter Martinsson, 2003. "Design techniques for stated preference methods in health economics," Health Economics, John Wiley & Sons, Ltd., vol. 12(4), pages 281-294, April.
  18. Johannesson, Magnus & Johansson, Per-Olov, 1997. "Quality of life and the WTP for an increased life expectancy at an advanced age," Journal of Public Economics, Elsevier, vol. 65(2), pages 219-228, August.
  19. George Van Houtven & John Powers & Amber Jessup & Jui‐Chen Yang, 2006. "Valuing avoided morbidity using meta‐regression analysis: what can health status measures and QALYs tell us about WTP?," Health Economics, John Wiley & Sons, Ltd., vol. 15(8), pages 775-795, August.
  20. Peter Nijkamp & Chiara Maria Travisi & Gabriella Vindigni, 2002. "Pesticide Risk Valuation in Empirical Economics," Tinbergen Institute Discussion Papers 02-112/3, Tinbergen Institute.
  21. Johansson, Per-Olov, 1997. "On the use of market prices to evaluate medical treatments," Journal of Health Economics, Elsevier, vol. 16(5), pages 609-615, October.
  22. Johannesson, Magnus & Johansson, Per-Olov, 1997. "Is the valuation of a QALY gained independent of age? Some empirical evidence," Journal of Health Economics, Elsevier, vol. 16(5), pages 589-599, October.
  23. David Whynes & Emma Frew & Jane Wolstenholme, 2005. "Willingness-to-Pay and Demand Curves: A Comparison of Results Obtained Using Different Elicitation Formats," International Journal of Health Economics and Management, Springer, vol. 5(4), pages 369-386, December.
  24. Karen Blumenschein & Glenn C. Blomquist & Magnus Johannesson & Nancy Horn & Patricia Freeman, 2008. "Eliciting Willingness to Pay Without Bias: Evidence from a Field Experiment," Economic Journal, Royal Economic Society, vol. 118(525), pages 114-137, January.
  25. Revesz, Richard & Stavins, Robert, 2004. "Environmental Law and Policy," Working Paper Series rwp04-023, Harvard University, John F. Kennedy School of Government.
  26. David K. Whynes & Jane L. Wolstenholme & Emma Frew, 2004. "Evidence of range bias in contingent valuation payment scales," Health Economics, John Wiley & Sons, Ltd., vol. 13(2), pages 183-190, February.
  27. Blomquist Glenn C. & Coomes Paul A. & Jepsen Christopher & Koford Brandon C. & Troske Kenneth R., 2014. "Estimating the social value of higher education: willingness to pay for community and technical colleges," Journal of Benefit-Cost Analysis, De Gruyter, vol. 5(1), pages 3-41, January.
  28. Juan Oliva & Félix Lobo & Julio López-Bastida & Néboa Zozaya & Rosa Romay, 2005. "Indirect costs of cervical and breast cancers in Spain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(4), pages 309-313, December.
  29. Philip M. Clarke, 2002. "Testing the convergent validity of the contingent valuation and travel cost methods in valuing the benefits of health care," Health Economics, John Wiley & Sons, Ltd., vol. 11(2), pages 117-127, March.
  30. Leiter, Andrea & Thöni, Magdalena & Winner, Hannes, 2012. "Evaluating human life using court decisions on damages for pain and suffering," International Review of Law and Economics, Elsevier, vol. 32(1), pages 119-128.
  31. Mark Harrison & Dan Rigby & Caroline Vass & Terry Flynn & Jordan Louviere & Katherine Payne, 2014. "Risk as an Attribute in Discrete Choice Experiments: A Systematic Review of the Literature," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 7(2), pages 151-170, June.
  32. Richard D. Smith, 2007. "The role of 'reference goods' in contingent valuation: should we help respondents to 'construct' their willingness to pay?," Health Economics, John Wiley & Sons, Ltd., vol. 16(12), pages 1319-1332.
  33. Mohammed Seid & Amare Minyihun & Gizachew Tilahun & Asmamaw Atnafu & Getasew Amare, 2021. "Willingness to pay for cataract surgery and associated factors among cataract patients in Outreach Site, North West Ethiopia," PLOS ONE, Public Library of Science, vol. 16(3), pages 1-15, March.
  34. Magnus Tambour & Niklas Zethraeus, 1998. "Nonparametric Willingness-to-pay Measures and Confidence Statements," Medical Decision Making, , vol. 18(3), pages 330-336, August.
  35. Ortiz, Ramon Arigoni & Markandya, Anil & Hunt, Alistair, 2009. "Willingness to Pay for Mortality Risk Reduction Associated with Air Pollution in Sao Paulo," Revista Brasileira de Economia - RBE, EPGE Brazilian School of Economics and Finance - FGV EPGE (Brazil), vol. 63(1), April.
  36. Rodgers Makwinja & Ishmael Bobby Mphangwe Kosamu & Chikumbusko Chiziwa Kaonga, 2019. "Determinants and Values of Willingness to Pay for Water Quality Improvement: Insights from Chia Lagoon, Malawi," Sustainability, MDPI, vol. 11(17), pages 1-26, August.
  37. Richard D. Smith, 2003. "Construction of the contingent valuation market in health care:a critical assessment," Health Economics, John Wiley & Sons, Ltd., vol. 12(8), pages 609-628, August.
  38. Gregory Ponthiere, 2008. "A Study of the Sensitivity of Longevity-adjusted Income Measures," Oxford Development Studies, Taylor & Francis Journals, vol. 36(3), pages 339-361.
  39. Bernard van denBerg & Werner Brouwer & Job van Exel & Marc Koopmanschap, 2005. "Economic valuation of informal care: the contingent valuation method applied to informal caregiving," Health Economics, John Wiley & Sons, Ltd., vol. 14(2), pages 169-183, February.
  40. Maria Travisi, Chiara & Nijkamp, Peter & Vindigni, Gabriella, 2006. "Pesticide risk valuation in empirical economics: a comparative approach," Ecological Economics, Elsevier, vol. 56(4), pages 455-474, April.
  41. Edward Calthrop & Stef Proost, 1998. "Road Transport Externalities," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 11(3), pages 335-348, April.
  42. Christine A. Kennedy, 2002. "Revealed preference valuation compared to contingent valuation: radon‐induced lung cancer prevention," Health Economics, John Wiley & Sons, Ltd., vol. 11(7), pages 585-598, October.
  43. Lamiraud, Karine & von Bremen, Konrade & Donaldson, Cam, 2009. "The impact of information on patient preferences in different delivery patterns: A contingent valuation study of prescription versus OTC drugs," Health Policy, Elsevier, vol. 93(2-3), pages 102-110, December.
  44. Zethraeus, Niklas & Johansson, Per-Olov, 1997. "Willingness to Pay for Hormone Replacement Therapy," SSE/EFI Working Paper Series in Economics and Finance 214, Stockholm School of Economics.
  45. Lamiraud, Karine & von Bremen, Konrade & Donaldson, Cam, 2009. "The impact of information on patient preferences in different delivery patterns: A contingent valuation study of prescription versus OTC drugs," Health Policy, Elsevier, vol. 93(2-3), pages 102-110, December.
  46. Richard D. Smith, 2007. "The role of ‘reference goods’ in contingent valuation: should we help respondents to ‘construct’ their willingness to pay?," Health Economics, John Wiley & Sons, Ltd., vol. 16(12), pages 1319-1332, December.
  47. Kimberly M. Thompson, 2002. "Data Requirements for Valuation of Children’s Health Effects and Alternatives to Valuation," NCEE Working Paper Series 200206, National Center for Environmental Economics, U.S. Environmental Protection Agency, revised Sep 2002.
  48. Johannesson, Magnus & Johansson, Per-Olov & Soderqvist, Tore, 1998. "Time spent on waiting lists for medical care: an insurance approach," Journal of Health Economics, Elsevier, vol. 17(5), pages 627-644, October.
  49. A. Freeman, 2006. "Valuing Environmental Health Effects – An Economic Perspective," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 34(3), pages 347-363, July.
  50. William S. Cartwright, 1998. "Cost-Benefit and Cost-Effectiveness Analysis of Drug Abuse Treatment Services," Evaluation Review, , vol. 22(5), pages 609-636, October.
  51. Johansson, Per-Olov, 1996. "On the value of changes in life expectancy," Journal of Health Economics, Elsevier, vol. 15(1), pages 105-113, February.
  52. Josue Mbonigaba & Wilfred Gbenga Akinola, 2021. "Productivity and Income Effect of Breast Cancer among Women in Southwestern Nigeria," Economies, MDPI, vol. 9(3), pages 1-19, September.
  53. Gregory Ponthiere, 2007. "Monetizing Longevity Gains under Welfare Interdependencies: An Exploratory Study," Journal of Family and Economic Issues, Springer, vol. 28(3), pages 449-469, September.
  54. Andrew Lloyd & Paul Hayes & Peter R. F. Bell & A. Ross Naylor, 2001. "The Role of Risk and Benefit Perception in Informed Consent for Surgery," Medical Decision Making, , vol. 21(2), pages 141-149, April.
  55. Jeroen C. J. M. van den Bergh & Kenneth J. Button, 1997. "Meta-analysis of Environmental Issues in Regional, Urban and Transport Economics," Urban Studies, Urban Studies Journal Limited, vol. 34(5-6), pages 927-944, May.
  56. Hugh Gravelle & Dave Smith, 2001. "Discounting for health effects in cost–benefit and cost‐effectiveness analysis," Health Economics, John Wiley & Sons, Ltd., vol. 10(7), pages 587-599, October.
  57. Blomquist, Glenn C. & Dickie, Mark & O'Conor, Richard M., 2011. "Willingness to pay for improving fatality risks and asthma symptoms: Values for children and adults of all ages," Resource and Energy Economics, Elsevier, vol. 33(2), pages 410-425, May.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.